supp.ai
Discover Supplement-Drug Interactions
Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago
supplement:
Epinephrine
drug:
Sulfinpyrazone
Research Papers that Mention the Interaction
“A significant (p less than 0.02) reduction (50%) of the aggregation response of platelet-rich plasma to epinephrine was found in the group treated with sulfinpyrazone (n = 21) as compared with the placebo group (n = 20).”
“Also, adrenaline evoked a milder (p less than 0.01) potentiation of aggregation by thrombin of the washed platelet suspensions in the sulfinpyrazone versus the placebo group.”
“It is concluded that sulfinpyrazone (200 mg 4 times daily) normalizes the platelet response to epinephrine ; a relation with the drug-reported reduction of sudden death after myocardial infarction is suggested.”
Sulfinpyrazone decreases epinephrine-induced platelet aggregation after myocardial infarction.“ Abstract Sulphinpyrazone at low concentrations inhibits the in vitro aggregation of normal platelets induced by epinephrine , collagen and ristocetin.”
“Abstract The inhibitory action … release inducible by epinephrine , comprising several non-…, phenylbutazone and sulfinpyrazone —and other non-anti-inflammatory agents (NAA)—prostaglandin E 1 , adenosine, dipyridamole, methysergide and cyproheptadine—can be prevented, … to human platelet rich plasma of the essential fatty acid, 5,8,11,14 eicosatetraenoic (arachidonic) acid.”
Help us improve supp.ai, we'd love to hear your feedback: Submit Feedback